S208: EFFICACY AND SAFETY OF ZANDELISIB ADMINISTERED BY INTERMITTENT DOSING (ID) IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA: PRIMARY ANALYSIS OF THE GLOBAL PHASE 2 STUDY TIDAL

oleh: A. Zelenetz, W. Jurczak, V. Ribrag, K. Linton, G. Collins, J. Lopéz-Jiménez, N. Reddy, A. Mengarelli, T. Phillips, G. Musuraca, O. Sheehy, J. Li, W. Xu, M. Azoulay, R. Ghalie, P. L. Zinzani